AGP Picks
View all

US Strike on Suspected Caribbean Drug Vessel Kills Four

(MENAFN) The US Southern Command announced on Wednesday that a military strike on a suspected drug-trafficking vessel in the Caribbean resulted in the deaths of four individuals.

Intelligence reportedly identified the vessel as operating along “known narco-trafficking routes” and actively participating in drug-related operations, according to a statement posted on a US social media platform.

The strike was authorized by SOUTHCOM commander Francis L. Donovan and executed by Joint Task Force Southern Spear against a vessel described as being run by “designated terrorist organizations.”

“Four male narco-terrorists were killed during this action. No U.S. military forces were harmed,” the statement said.

The operation is part of an intensified US military effort in the Caribbean Sea and eastern Pacific Ocean that began in September, aimed at combating narcotics trafficking. Authorities note that at least 163 people have been killed since these operations started.

MENAFN26032026000045017640ID1110909270


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Military Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.